FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3148726265> ?p ?o ?g. }

• W3148726265 endingPage "987" @default.
• W3148726265 startingPage "975" @default.
• W3148726265 abstract "Abstract Coronavirus disease 2019 (COVID-19) has spread rapidly throughout the globe. The spectrum of disease is broad but among hospitalized patients with COVID-19, respiratory failure from acute respiratory distress syndrome is the leading cause of mortality. There is an urgent need for an effective treatment. The current focus has been developing novel therapeutics, including antivirals, protease inhibitors, vaccines and targeting the overactive cytokine response with anti-cytokine therapy. The overproduction of early response proinflammatory cytokines results in what has been described as a “cytokine storm” is leading eventually to death when the cells fail to terminate the inflammatory response. Accumulating evidence shows that inflammatory cytokines induce selectin ligands that play a crucial role in the pathogenesis of inflammatory diseases by mediating leukocyte migration from the blood into the tissue. Thus, the selectins and selectin ligands represent a promising therapeutic target for the treatment of COVID-19. In this paper, potential pan-selectin inhibitors were identified employing a virtual screening using a docking procedure. For this purpose, the Asinex and ZINC databases of ligands, including approved drugs, biogenic compounds and glycomimetics, altogether 923,602 compounds, were screened against the P-, L- and E-selectin. At first, the experimentally confirmed inhibitors were docked into all three selectins’ carbohydrate recognition domains to assess the suitability of the screening procedure. Finally, based on the evaluation of ligands binding, we propose 10 purchasable pan-selectin inhibitors to develop COVID-19 therapeutics." @default.
• W3148726265 created "2021-04-13" @default.
• W3148726265 creator A5006856491 @default.
• W3148726265 creator A5016686816 @default.
• W3148726265 creator A5043139384 @default.
• W3148726265 creator A5061853775 @default.
• W3148726265 date "2021-04-01" @default.
• W3148726265 modified "2023-10-17" @default.
• W3148726265 title "Pan-selectin inhibitors as potential therapeutics for COVID-19 treatment: in silico screening study" @default.
• W3148726265 cites W1578502196 @default.
• W3148726265 cites W1591171876 @default.
• W3148726265 cites W1757990252 @default.
• W3148726265 cites W176966499 @default.
• W3148726265 cites W1833091681 @default.
• W3148726265 cites W187926325 @default.
• W3148726265 cites W1900762885 @default.
• W3148726265 cites W1955707222 @default.
• W3148726265 cites W1983004361 @default.
• W3148726265 cites W1985588649 @default.
• W3148726265 cites W1987081782 @default.
• W3148726265 cites W1989978944 @default.
• W3148726265 cites W1990724722 @default.
• W3148726265 cites W1991889240 @default.
• W3148726265 cites W2009423060 @default.
• W3148726265 cites W2025019998 @default.
• W3148726265 cites W2027423337 @default.
• W3148726265 cites W2027482274 @default.
• W3148726265 cites W2031168104 @default.
• W3148726265 cites W2036367942 @default.
• W3148726265 cites W2043509228 @default.
• W3148726265 cites W2052312474 @default.
• W3148726265 cites W2055033432 @default.
• W3148726265 cites W2055044750 @default.
• W3148726265 cites W2055468986 @default.
• W3148726265 cites W2057628693 @default.
• W3148726265 cites W2069168579 @default.
• W3148726265 cites W2087710697 @default.
• W3148726265 cites W2092407400 @default.
• W3148726265 cites W2101764813 @default.
• W3148726265 cites W2102377211 @default.
• W3148726265 cites W2107160157 @default.
• W3148726265 cites W2109153347 @default.
• W3148726265 cites W2112998064 @default.
• W3148726265 cites W2149170824 @default.
• W3148726265 cites W2153354364 @default.
• W3148726265 cites W2155480470 @default.
• W3148726265 cites W2155793158 @default.
• W3148726265 cites W2157453847 @default.
• W3148726265 cites W2159201548 @default.
• W3148726265 cites W2159417266 @default.
• W3148726265 cites W2168983825 @default.
• W3148726265 cites W2176516200 @default.
• W3148726265 cites W2204695023 @default.
• W3148726265 cites W2222589778 @default.
• W3148726265 cites W2327497354 @default.
• W3148726265 cites W2335351410 @default.
• W3148726265 cites W2565348719 @default.
• W3148726265 cites W2625021681 @default.
• W3148726265 cites W2774836366 @default.
• W3148726265 cites W3009885589 @default.
• W3148726265 cites W3015030076 @default.
• W3148726265 cites W3023982717 @default.
• W3148726265 cites W3036288118 @default.
• W3148726265 cites W3036930405 @default.
• W3148726265 cites W3111279864 @default.
• W3148726265 cites W3111668370 @default.
• W3148726265 cites W4233994049 @default.
• W3148726265 doi "https://doi.org/10.1093/glycob/cwab021" @default.
• W3148726265 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8083503" @default.
• W3148726265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33822042" @default.
• W3148726265 hasPublicationYear "2021" @default.
• W3148726265 type Work @default.
• W3148726265 sameAs 3148726265 @default.
• W3148726265 citedByCount "7" @default.
• W3148726265 countsByYear W31487262652021 @default.
• W3148726265 countsByYear W31487262652022 @default.
• W3148726265 countsByYear W31487262652023 @default.
• W3148726265 crossrefType "journal-article" @default.
• W3148726265 hasAuthorship W3148726265A5006856491 @default.
• W3148726265 hasAuthorship W3148726265A5016686816 @default.
• W3148726265 hasAuthorship W3148726265A5043139384 @default.
• W3148726265 hasAuthorship W3148726265A5061853775 @default.
• W3148726265 hasBestOaLocation W31487262651 @default.
• W3148726265 hasConcept C104317684 @default.
• W3148726265 hasConcept C126322002 @default.
• W3148726265 hasConcept C155619193 @default.
• W3148726265 hasConcept C164027704 @default.
• W3148726265 hasConcept C185592680 @default.
• W3148726265 hasConcept C203014093 @default.
• W3148726265 hasConcept C2775905019 @default.
• W3148726265 hasConcept C2776914184 @default.
• W3148726265 hasConcept C2778690821 @default.
• W3148726265 hasConcept C2779134260 @default.
• W3148726265 hasConcept C2779559532 @default.
• W3148726265 hasConcept C3008058167 @default.
• W3148726265 hasConcept C524204448 @default.
• W3148726265 hasConcept C55493867 @default.
• W3148726265 hasConcept C71924100 @default.

• next